1. Home
  2. MYGN vs LION Comparison

MYGN vs LION Comparison

Compare MYGN & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$6.45

Market Cap

625.5M

Sector

Health Care

ML Signal

HOLD

Logo Lionsgate Studios Corp.

LION

Lionsgate Studios Corp.

HOLD

Current Price

$9.23

Market Cap

2.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
LION
Founded
1991
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
625.5M
2.4B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
MYGN
LION
Price
$6.45
$9.23
Analyst Decision
Buy
Buy
Analyst Count
12
10
Target Price
$11.82
$9.11
AVG Volume (30 Days)
910.3K
3.1M
Earning Date
11-03-2025
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$825,300,000.00
$3,858,000,000.00
Revenue This Year
$0.08
N/A
Revenue Next Year
$5.28
$22.30
P/E Ratio
N/A
N/A
Revenue Growth
0.21
21.18
52 Week Low
$3.76
$5.55
52 Week High
$15.47
$9.41

Technical Indicators

Market Signals
Indicator
MYGN
LION
Relative Strength Index (RSI) 39.01 76.84
Support Level $6.38 $8.21
Resistance Level $6.89 $9.25
Average True Range (ATR) 0.29 0.43
MACD -0.06 0.09
Stochastic Oscillator 5.71 92.52

Price Performance

Historical Comparison
MYGN
LION

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

About LION Lionsgate Studios Corp.

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

Share on Social Networks: